Trial Profile
Effect of gemfibrozil on the pharmacokinetics of imatinib in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Sep 2013
Price :
$35
*
At a glance
- Drugs Imatinib (Primary) ; Gemfibrozil
- Indications Chronic myeloid leukaemia; Dermatofibrosarcoma; Dyslipidaemias; Fibroma; Gastrointestinal stromal tumours; Lipid metabolism disorders; Malignant melanoma; Mastocytosis; Myelodysplastic syndromes; Non-small cell lung cancer; Precursor cell lymphoblastic leukaemia-lymphoma; Prostate cancer; Sarcoma
- Focus Pharmacogenomic; Pharmacokinetics
- 19 Sep 2013 New trial record
- 31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.